Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy AstraZeneca Nawigacja wpisu What’s driving the federal probe of Dartmouth’s Geisel School of Medicine? – New Hampshire Public Radio
